Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Zhongguo Zhong Yao Za Zhi ; 49(3): 763-769, 2024 Feb.
Article in Chinese | MEDLINE | ID: mdl-38621880

ABSTRACT

This study aims to investigate the effect of Erchen Decoction(ECD) on liver mitochondrial function in mice with a high-fat diet and its possible mechanism. A total of sixty C57BL/6J mice were randomly divided into a normal group, high-fat group, ECD group, mTORC1 activator(MHY) group, ECD+MHY group, and polyene phosphatidyl choline(PPC) group, with 10 rats in each group. The normal group was given a normal diet, and the other groups were fed a high-fat diet for 20 weeks. At the 17th week, the ECD group and ECD+MHY group were given ECD(8.7 g·kg~(-1)) daily, and the PPC group was given PPC(0.18 g·kg~(-1)) daily, while the remaining groups were given normal saline(0.01 mL·g~(-1)) daily for four weeks. In the 19th week, the MHY group and ECD+MHY group were injected intraperitoneally with MHY(5 mg·kg~(-1)) every other day for two weeks. During the experiment, the general conditions of the mice were observed. The contents of triglyceride(TG) and total cholesterol(TC) in serum were measured. Morphological changes in liver tissue were examined through HE and oil red O staining. The content of adenosine triphosphate(ATP) was determined using chemiluminescence, and mitochondrial membrane potential was assessed using a fluorescence probe(JC-1). Western blot was performed to detect the expression of rapamycin target protein complex 1(mTOR1), ribosomal protein S6 kinase B1(S6K), sterol regulatory element binding protein 1(SREBP1), and caveolin 1(CAV1). RESULTS:: revealed that compared with the normal group, the mice in the high-fat group exhibited significant increases in body weight and abdominal circumference(P<0.01). Additionally, there were significant increases in TG and TC levels(P<0.01). HE and oil red O staining showed that the boundaries of hepatic lobules were unclear; hepatocytes were enlarged, round, and irregularly arranged, with obvious lipid droplet deposition and inflammatory cell infiltration. The liver ATP content and mitochondrial membrane potential decreased significantly(P<0.01). The expression of p-mTOR, p-S6K, and n-SREBP1 increased significantly(P<0.01), while the expression of CAV1 decreased significantly(P<0.01). Compared with the high-fat group, the body weight and TG content of mice in the ECD group and PPC group decreased significantly(P<0.05). Improvements were observed in hepatocyte morphology, lipid deposition, and inflammatory cell infiltration. Furthermore, there were significant increases in ATP content and mitochondrial membrane potential(P<0.05 or P<0.01). The expression of p-mTOR, p-S6K, and n-SREBP1 decreased significantly in the ECD group(P<0.01), while CAV1 expression increased significantly(P<0.01). However, the indices mentioned above did not show improvement in the MHY group. When the ECD+MHY group was compared with the MHY group, there were significant reductions in body weight and TG contents(P<0.05). The morphological changes of hepatocytes, lipid deposition, and inflammatory cell infiltration were recovered. Moreover, there were significant increases in liver ATP content and mitochondrial membrane potential(P<0.05 or P<0.05). The expression of p-mTOR, p-S6K, and n-SREBP1 decreased significantly(P<0.01), while CAV1 expression increased significantly(P<0.01). In conclusion, ECD can improve mitochondrial function by regulating the mTORC1/SREBP1/CAV1 pathway. This mechanism may be involved in the resolution of phlegm syndrome and the regulation of lipid metabolism.


Subject(s)
Azo Compounds , Diet, High-Fat , Non-alcoholic Fatty Liver Disease , Mice , Rats , Animals , Diet, High-Fat/adverse effects , Mechanistic Target of Rapamycin Complex 1/metabolism , Mechanistic Target of Rapamycin Complex 1/pharmacology , Caveolin 1/metabolism , Caveolin 1/pharmacology , Mice, Inbred C57BL , Liver , Non-alcoholic Fatty Liver Disease/metabolism , TOR Serine-Threonine Kinases/metabolism , Triglycerides/metabolism , Body Weight , Adenosine Triphosphate/pharmacology
2.
Zhongguo Zhong Yao Za Zhi ; 46(22): 5773-5780, 2021 Nov.
Article in Chinese | MEDLINE | ID: mdl-34951164

ABSTRACT

With the widespread application of next-generation sequencing(NGS), especially 16 S rRNA and shotgun sequencing, researchers are no longer troubled with massive data on the gut microbiota, and the correlation between the gut microbiota and the brain(central nervous system) has been gradually revealed. Research on the microbiota-gut-brain axis(MGBA) based on the gut microbiota have provided insights into the exploration of the pathogenesis and risk factors of ischemic stroke(IS), a cerebrovascular disease with high disability and mortality rates, and also facilitate the selection of therapeutic targets of this class of drugs. This study reviewed the application of NGS in the study of gut microbiota and the research progress of MGBA in recent years and systematically collated the research papers on the correlation between IS and gut microbiota. Furthermore, from the bi-directional regulation of MGBA, this study also discussed the high-risk factors of IS under the dysregulation of gut microbiota and the pathophysiological changes of gut microbiota after the occurrence of IS and summarized the related targets to provide a reliable reference for the therapeutic research of IS from the gut microbiota.


Subject(s)
Gastrointestinal Microbiome , Ischemic Stroke , Stroke , Brain , Brain-Gut Axis , Humans , Stroke/genetics
3.
Zhongguo Zhong Yao Za Zhi ; 45(12): 2975-2981, 2020 Jun.
Article in Chinese | MEDLINE | ID: mdl-32627475

ABSTRACT

In this study, we explored the antibacterial effect and mechanism of dihydroartemisinin(DHA) combined with cefuroxime(CFX) or ampicillin against Escherichia coli. The minimum inhibitory concentration(MIC) of DHA, cefuroxime, and ampicillin against E. coli was 300,25,25 µmol·L~(-1), respectively, determined by broth microdilution method and 2,3,5-triphenyltetrazolium chloride(TTC) method. The minimum bactericidal concentration(MBC) was 25 µmol·L~(-1) for cefuroxime, above 600 µmol·L~(-1) for DHA. The fractional inhibitory concentration index(FICI) of DHA combined with cefuroxime or ampicillin was 0.375 and 0.75, respectively, determined by checkerboard microdilution assay, suggesting the synergistic effect or additive effect of the drug combination. Moreover, the time-effect curve showed that the antibacterial activity of DHA and CFX combination was much stronger than that of either of the drugs, suggesting that combination with DHA can decrease the CFX dosage. Then we studied the synergistic mechanism of DHA combined with cefuroxime and found that the combination of the two drugs had a significant inhibitory effect on the total protein bands, as shown by the results of polypropylene gel electrophoresis. The results of conductivity method and alkaline phosphatase test respectively showed that its conductivity value and alkaline phosphatase(AKP) leak were significantly higher than either of the drugs, suggesting that the integrity of bacteria may be damaged. The scanning electron microscope(SEM) results showed that the morphology of E. coli was destroyed most in the combination group. The quantitative fluorescence PCR technology showed that the combination of two drugs can inhibit the expression of superoxide stress gene soxS. In summary, the combination of dihydroartemisinin and cefuroxime has a synergistic antibacterial effect on E. coli.


Subject(s)
Cefuroxime , Escherichia coli , Anti-Bacterial Agents , Artemisinins , Drug Synergism , Microbial Sensitivity Tests
4.
Zhongguo Zhong Yao Za Zhi ; 44(9): 1946-1952, 2019 May.
Article in Chinese | MEDLINE | ID: mdl-31342725

ABSTRACT

In this study,in order to detect the antimicrobial activity of artemisinin and its derivatives artesunate and dihydroartemisinin,two methods including broth dilution and plate punching method were used to detect the antibacterial activity against gram-negative bacteria(Escherichia coli)and gram-positive bacteria(Staphylococcus aureus)of artemisinin,dihydroartemisinin and artesunate at various concentrations within 5 mmol·L~(-1)and at four time points(8,16,24,32 h).Two antibacterial positive drugs,streptomycin against E.coli and penicillin against S.aureus,were used as positive controls.Plate punching method showed that,unlike the results of 5 mmol·L~(-1)dihydroartemisinin or artesunate,no inhibition zone was detected at the same concentration of artemisinin after 24 h-treatment against E.coli.Broth dilution method showed that,the antibacterial activity of dihydroartemisinin against E.coli.was stronger than those of both artesunate and artemisinin;IC_(50)at24 h-treatment was 155.9µmol·L~(-1)for dihydroartemisinin,370.0µmol·L~(-1)for artesunate and none for artemisinin.Interestingly,dihydroartemisinin and artesunate showed the strongest antibacterial activity between 16-24 h,while artemisinin showed relatively stronger antibacterial activity between 8-16 h.Dihydroartermisinin showed no antibacterial activity against S.aureus.Above all,the antibacterial activity of artemisinins against E.coli is dihydroartemisinin>artesunate>artemisinin.Artemisinin and its derivatives have showed different antibacterial kinetics,and no antibacterial activity against S.aureus.has been detected with dihydroartemisinin.


Subject(s)
Anti-Bacterial Agents/pharmacology , Artemisinins/pharmacology , Escherichia coli/drug effects , Staphylococcus aureus/drug effects , Artesunate/pharmacology , Microbial Sensitivity Tests
5.
CNS Neurosci Ther ; 24(1): 70-79, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29125684

ABSTRACT

BACKGROUND: Environmental enrichment (EE) has been shown to enhance cognitive function in mouse models of Alzheimer's disease (AD). Magnesium-L-threonate (MgT) is a compound with a newly discovered effect to rescue learning and memory function in aging and AD mice. AIM: To study the additive therapeutic effect of EE combined with MgT (EM) and the potential mechanism underlying the effects. MATERIALS AND METHODS: APP/PS1 mice were treated with EE, MgT, or combination of EE and MgT (EM) and compared for restored memory function. RESULTS: EM was more effective in improving cognition and spatial memory than either treatment alone in either long-term (12 months, started at 3 months old, which was before disease manifestation) or short-term (3 months, started at 6 months old, which was after disease manifestation) treatment. The behavioral improvement has coincided with rescue of synaptic contacts in the hippocampal region of the AD mouse brain. Immunoblots also showed that EM but neither single treatment rescued the activity reduction in CaMKII and CREB, two important downstream molecules in the N-methyl-D-aspartate receptor (NMDAR) pathway. CONCLUSION: Environmental enrichment and MgT may synergistically improve recognition and spatial memory by reducing synaptic loss and restoring the NMDAR signaling pathway in AD mice, which suggests that combination of EE and MgT may be a novel therapeutic strategy for AD.


Subject(s)
Alzheimer Disease/complications , Alzheimer Disease/therapy , Environment , Magnesium/therapeutic use , Memory Disorders/etiology , Memory Disorders/therapy , Alzheimer Disease/genetics , Alzheimer Disease/pathology , Amyloid beta-Protein Precursor/genetics , Animals , CREB-Binding Protein/metabolism , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Disease Models, Animal , Humans , Maze Learning/drug effects , Maze Learning/physiology , Mice , Mice, Transgenic , Mutation/genetics , Presenilin-1/genetics , Receptors, N-Methyl-D-Aspartate/metabolism , Recognition, Psychology , Signal Transduction/drug effects , Signal Transduction/genetics , Synapses/drug effects , Synapses/pathology , Time Factors
6.
Braz. j. microbiol ; 48(3): 544-550, July-Sept. 2017. tab, graf
Article in English | LILACS | ID: biblio-889154

ABSTRACT

Abstract Presence of the relatively new sulfonylurea herbicide monosulfuron-ester at 0.03-300 nmol/L affected the growth of two non-target nitrogen-fixing cyanobacteria (Anabaena flos-aquae and Anabaena azotica) and substantially inhibited in vitro Acetolactate synthase activity, with IC50 of 3.3 and 101.3 nmol/L for A. flos-aquae and A. azotica, respectively. Presenting in 30-300 nmol/L, it inhibited protein synthesis of the cyanobacteria with less amino acids produced as its concentration increased. Our findings support the view that monosulfuron-ester toxicity in both nitrogen-fixing cyanobacteria is due to its interference with protein metabolism via inhibition of branch-chain amino acid biosynthesis, and particularly Acetolactate synthase activity.


Subject(s)
Pyrimidines/toxicity , Sulfonylurea Compounds/toxicity , Anabaena/drug effects , Anabaena/metabolism , Dolichospermum flos-aquae/drug effects , Dolichospermum flos-aquae/metabolism , Esters/toxicity , Herbicides/toxicity , Nitrogen Fixation/drug effects , Anabaena/genetics , Dolichospermum flos-aquae/genetics , Amino Acids/metabolism , Nitrogen/metabolism
7.
Braz J Microbiol ; 48(3): 544-550, 2017.
Article in English | MEDLINE | ID: mdl-28454676

ABSTRACT

Presence of the relatively new sulfonylurea herbicide monosulfuron-ester at 0.03-300nmol/L affected the growth of two non-target nitrogen-fixing cyanobacteria (Anabaena flos-aquae and Anabaena azotica) and substantially inhibited in vitro Acetolactate synthase activity, with IC50 of 3.3 and 101.3nmol/L for A. flos-aquae and A. azotica, respectively. Presenting in 30-300nmol/L, it inhibited protein synthesis of the cyanobacteria with less amino acids produced as its concentration increased. Our findings support the view that monosulfuron-ester toxicity in both nitrogen-fixing cyanobacteria is due to its interference with protein metabolism via inhibition of branch-chain amino acid biosynthesis, and particularly Acetolactate synthase activity.


Subject(s)
Anabaena/drug effects , Anabaena/metabolism , Dolichospermum flos-aquae/drug effects , Dolichospermum flos-aquae/metabolism , Esters/toxicity , Herbicides/toxicity , Nitrogen Fixation/drug effects , Pyrimidines/toxicity , Sulfonylurea Compounds/toxicity , Amino Acids/metabolism , Anabaena/genetics , Dolichospermum flos-aquae/genetics , Nitrogen/metabolism
8.
Neurosci Bull ; 32(6): 577-584, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27761788

ABSTRACT

Nogo-66 plays a central role in the myelin-mediated inhibition of neurite outgrowth. Tau is a microtubule-associated protein involved in microtubule assembly and stabilization. It remains unverified whether tau interacts directly with growth factor receptors, or engages in cross-talk with regeneration inhibitors like Nogo-66. Here, we report that plasmid overexpression of tau significantly elevated the protein levels of total tau, phosphorylated tau, and microtubule-affinity regulating kinase (MARK). Nogo-66 transiently elevated the total tau protein level and persistently reduced the level of p-S262 tau (tau phosphorylated at serine 262), whereas it had little influence on the level of p-T205 tau (tau phosphorylated at threonine 205). Nogo-66 significantly decreased the protein level of MARK. Hymenialdisine, an inhibitor of MARK, significantly reduced the level of p-S262 tau. Overexpression of tau rescued the Nogo-66-induced inhibition of neurite outgrowth in neuroblastoma 2a (N2a) cells and primary cortical neurons. However, concomitant inhibition of MARK abolished the rescue of neurite outgrowth by tau in N2a cells. We conclude that dephosphorylation of tau at S262 is able to regulate Nogo-66 signaling, and that overexpression of tau can rescue the Nogo-66-induced inhibition of neurite outgrowth in vitro.


Subject(s)
Neurites/drug effects , Neurons/cytology , Neurons/drug effects , Nogo Proteins/pharmacology , tau Proteins/metabolism , Analysis of Variance , Animals , Azepines/pharmacology , Cells, Cultured , Cerebral Cortex/cytology , Embryo, Mammalian , Enzyme Inhibitors/pharmacology , Female , Gene Expression Regulation/drug effects , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Mice , Neuroblastoma/pathology , Protein Serine-Threonine Kinases/metabolism , Pyrroles/pharmacology , Rats , Rats, Sprague-Dawley , Time Factors , Transfection , tau Proteins/genetics
9.
Neurochem Res ; 41(11): 2958-2968, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27465397

ABSTRACT

The ability of neurons in the adult mammalian central nervous system (CNS) to regenerate after injury is limited by inhibitors in CNS myelin. Nogo-66 is the most important myelin inhibitor but the mechanisms of Nogo-66 inhibition of neurite outgrowth remain poorly understood. Particularly, the relationship between Nogo-66 and microtubule-affinity regulating kinase 2 (MARK2) has not been examined. This study investigated the role of MARK2 in Nogo-66 inhibition and the function of MARK2 in neurite elongation in neurons in vitro. MARK2 and phosphorylated MARK2 at Ser212 (p-Ser212) alterations in Neuro 2a cells were assessed at different Nogo-66 exposure times; the relationships between MARK2 and microtubule-associated proteins (MAPs) were determined via the overexpression or interference of MARK2. Our study reports that Nogo-66 inhibited the expression of total MARK2 but also reduced Ser212 phosphorylation of MARK2, whereas levels of MAP1-b and tau varied depending on MARK2 overexpression or reduced expression. Furthermore, MARK2 increased the proportion of tyrosinated α-tubulin, thereby disrupting the stability of tubulin, most likely affecting axonal growth. In line with these results, overexpression of MARK2 promoted neurite elongation and therefore is able to rescue the inhibitory effect of Nogo-66 on neurite growth. In conclusion, the intracellular PKB/MARK2/MAPs/α-tubulin pathway appears to be essential for neurite elongation in neurons in vitro. These results suggest a critical role for MARK2 in overcoming Nogo-66-induced inhibition of axon outgrowth in neurons. Pharmacological activators of MARK2 may be applicable to promote successful axonal outgrowth following many types of CNS injuries.


Subject(s)
Microtubule-Associated Proteins/metabolism , Myelin Proteins/metabolism , Neurites/physiology , Neuronal Outgrowth/physiology , Peptide Fragments/metabolism , Protein Serine-Threonine Kinases/metabolism , Animals , Microtubules/metabolism , Phosphorylation , Rats, Sprague-Dawley
10.
Chin Med J (Engl) ; 128(14): 1956-63, 2015 Jul 20.
Article in English | MEDLINE | ID: mdl-26168838

ABSTRACT

BACKGROUND: Appropriate expression and regulation of the transcriptome, which mainly comprise of mRNAs and lncRNAs, are important for all biological and cellular processes including the physiological activities of bone microvascular endothelial cells (BMECs). Through an intricate intracellular signaling systems, the transcriptome regulates the pharmacological response of the cells. Although studies have elucidated the impact of glucocorticoids (GCs) cell-specific gene expression signatures, it remains necessary to comprehensively characterize the impact of lncRNAs to transcriptional changes. METHODS: BMECs were divided into two groups. One was treated with GCs and the other left untreated as a paired control. Differential expression was analyzed with GeneSpring software V12.0 (Agilent, Santa Clara, CA, USA) and hierarchical clustering was conducted using Cluster 3.0 software. The Gene Ontology (GO) analysis was performed with Molecular Annotation System provided by CapitalBio Corporation. RESULTS: Our results highlight the involvement of genes implicated in development, differentiation and apoptosis following GC stimulation. Elucidation of differential gene expression emphasizes the importance of regulatory gene networks induced by GCs. We identified 73 up-regulated and 166 down-regulated long noncoding RNAs, the expression of 107 of which significantly correlated with 172 mRNAs induced by hydrocortisone. CONCLUSIONS: Transcriptome analysis of BMECs from human samples was performed to identify specific gene networks induced by GCs. Our results identified complex RNA crosstalk underlying the pathogenesis of steroid-induced necrosis of femoral head.


Subject(s)
Endothelial Cells/drug effects , Endothelial Cells/metabolism , Femur Head/cytology , Glucocorticoids/pharmacology , Transcriptome/genetics , Cells, Cultured , Gene Expression Profiling , Humans , Oligonucleotide Array Sequence Analysis , Osteonecrosis/genetics , RNA, Messenger/genetics , RNA, Untranslated/genetics , Transcriptome/drug effects
11.
Neurosci Bull ; 30(6): 923-935, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25391447

ABSTRACT

Amyloid ß-peptide (Aß) has been implicated as a key molecule in the neurodegenerative cascades of Alzheimer's disease (AD). Humanin (HN) is a secretory peptide that inhibits the neurotoxicity of Aß. However, the mechanism(s) by which HN exerts its neuroprotection against Aß-induced AD-like pathological changes and memory deficits are yet to be completely defined. In the present study, we provided evidence that treatment of rats with HN increases the number of dendritic branches and the density of dendritic spines, and upregulates pre- and post-synaptic protein levels; these effects lead to enhanced long-term potentiation and amelioration of the memory deficits induced by Aß(1-42). HN also attenuated Aß(1-42)-induced tau hyperphosphorylation, apparently by inhibiting the phosphorylation of Tyr307 on the inhibitory protein phosphatase-2A (PP2A) catalytic subunit and thereby activating PP2A. HN also inhibited apoptosis and reduced the oxidative stress induced by Aß(1-42). These findings provide novel mechanisms of action for the ability of HN to protect against Aß(1-42)-induced AD-like pathological changes and memory deficits.


Subject(s)
Alzheimer Disease/drug therapy , Brain/drug effects , Cognition Disorders/drug therapy , Dendrites/drug effects , Intracellular Signaling Peptides and Proteins/therapeutic use , Maze Learning/drug effects , Alzheimer Disease/chemically induced , Alzheimer Disease/pathology , Amyloid beta-Peptides , Animals , Brain/pathology , Cognition/drug effects , Cognition Disorders/pathology , Cognition Disorders/psychology , Dendrites/pathology , Dendritic Spines/drug effects , Dendritic Spines/pathology , Disease Models, Animal , Hippocampus/drug effects , Hippocampus/pathology , Intracellular Signaling Peptides and Proteins/pharmacology , Male , Neurons/drug effects , Neurons/pathology , Oxidative Stress/drug effects , Phosphorylation/drug effects , Rats , Rats, Wistar
12.
Neurosci Lett ; 505(2): 165-70, 2011 Nov 14.
Article in English | MEDLINE | ID: mdl-22019984

ABSTRACT

The axons of the adult mammalian brain and spinal cord fail to regenerate after injury, and it has been suggested that Nogo-66 could prevent CNS axon repair. However, the mechanism of Nogo-66 inhibiting neurite outgrowth remains unknown. Our previous results indicated that protein kinase B (PKB) is involved in the inhibition of the neurite outgrowth by Nogo-66. Glycogen synthase kinase-3ß (GSK-3ß) is implicated in many processes in the nervous system, including differentiation, specification, polarity, plasticity and axon growth. In addition, GSK-3ß is one of the most important molecules downstream of PKB. In the present study, we report on the role of GSK-3ß signaling on Nogo-66-treated mouse neuroblastoma N2a cells. Nogo-66 reduced the phosphorylation of GSK-3ß at Ser9 in N2a cells. In contrast, pretreatment with SB216763, a specific inhibitor of GSK-3ß, resulted in an amelioration of neurite outgrowth by Nogo-66, compared with the Nogo-66 alone group (P<0.05). Moreover, we performed RNA interference experiments to knock down GSK-3ß expression levels in N2a cells via transient transfection of shRNA plasmids. The inhibition of neurite outgrowth by Nogo-66 was subdued in shRNA cells, compared to the non-RNAi cells (P<0.05). Taken together, these data suggest that GSK-3ß is involved in the inhibition by Nogo-66 of neurite outgrowth in N2a cells.


Subject(s)
Glycogen Synthase Kinase 3/metabolism , Myelin Proteins/physiology , Nerve Regeneration/physiology , Neural Inhibition/genetics , Neurites/metabolism , Neurogenesis/physiology , Receptors, Cell Surface/physiology , Animals , Cell Line, Tumor , Enzyme Activation/drug effects , Enzyme Activation/genetics , GPI-Linked Proteins/physiology , Glycogen Synthase Kinase 3/antagonists & inhibitors , Glycogen Synthase Kinase 3/genetics , Glycogen Synthase Kinase 3 beta , Indoles/pharmacology , Maleimides/pharmacology , Mice , Nerve Regeneration/drug effects , Neural Inhibition/drug effects , Neural Inhibition/physiology , Neurites/pathology , Neuroblastoma/metabolism , Neuroblastoma/pathology , Neurogenesis/drug effects , Nogo Receptor 1 , Phosphorylation/drug effects , Phosphorylation/genetics , RNA Interference/drug effects , RNA, Small Interfering/genetics
13.
Shanghai Kou Qiang Yi Xue ; 18(2): 173-7, 2009 Apr.
Article in Chinese | MEDLINE | ID: mdl-19417995

ABSTRACT

PURPOSE: The study was designed to observe the effects of the smokeless tobacco extract(ST) on the attachment,morphology,structure and proliferation of rat gingival fibroblasts(RGFs) to titanium in vitro. METHODS: RGFs were obtained from explants of rat normal gingival tissues by using tissue-explant technique.The origin of cells was identified by immunochemistry of vimentin and cytokeratin. RGFs to titanium were cultured in the presence of ST at various concentration,the attachment and growth of cells attached to titanium were measured by MTT method, immunofluorescence was used to detect and analyze the shapes of RGFs attached to titanium.Statistical analysis was performed using SPSS13.0 software package for one-way ANOVA. RESULTS: Immunochemical study showed that vimentin was expressed in RGFs while cytokeratin was negative,which indicated that RGFs were originated from mesoblastoma.With the increasing of ST concentration,the attachment,spreading shape and proliferation of RGFs in all groups decreased in a concentration-dependent manner.The difference between ST group and control group was statistically significant(P<0.05). CONCLUSIONS: ST can inhibit the attachment,spreading shape and proliferation of RGFs, suggesting that smoking may have influence on the long result of oral implant operation.


Subject(s)
Nicotiana , Titanium , Animals , Cell Adhesion , Cells, Cultured , Fibroblasts , Gingiva , Rats
14.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 27(2): 151-4, 2007 Feb.
Article in Chinese | MEDLINE | ID: mdl-17343004

ABSTRACT

OBJECTIVE: To preliminarily investigate the influence of hypoxia on human umbilical vein endothelial cells (HUVECs), and the effect of Ginkgo biloba extract 50 (GBE50) on it. METHODS: Flow cytometry, TUNEL, RT-PCR, Western blot, etc. were applied, to study the effect of hypoxia and GBE50 on endothelial cells. RESULTS: After being interfered by hypoxia for 24 h, the levels of reactive oxygen species (ROS) in HUVECs and the apoptotic rate either in the early or in the late stage significantly increased, and accompanied with the increased levels of endothelin-1 mRNA (ET-1) and endothelial oxide synthase (eNOS) protein. However, when HUVECs were pretreated with GBE50 (25 [microg/ml) 4 h before hypoxia, the apoptotic rate in the early or late stage and expression of ET-1 mRNA significantly decreased (P < 0.05), and the heightened ROS level and eNOS expression partially decreased (P > 0.05). CONCLUSION: Hypoxia can induce endothelial dysfunction, which could be partially or significantly reversed by GBE50, it shows a certain protective effect on hypoxia induced endothelial dysfunction.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Endothelial Cells/drug effects , Ginkgo biloba/chemistry , Blotting, Western , Cell Hypoxia , Cells, Cultured , Endothelial Cells/metabolism , Endothelin-1/biosynthesis , Endothelin-1/genetics , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Endothelium, Vascular/physiopathology , Free Radical Scavengers/pharmacology , Humans , Plant Leaves/chemistry , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Reactive Oxygen Species/metabolism , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...